Medford, MA, United States of America

Michael Biasella

This inventor holds 2 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Fractyl Health, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Biasella. Retrieved from https://idiyas.com/inventor/michael-biasella

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Biasella - Innovator in Metabolic Disease Treatment

Introduction

Michael Biasella is an inventor based in Medford, MA (US). He currently works at Fractyl Health, Inc., where he focuses on developing innovative solutions for treating metabolic diseases. Although he has not yet been granted any patents, his work is significant in the field of medical technology.

Latest Patent Applications

Michael Biasella has submitted several patent applications, including a notable one titled "System for Treating a Patient." This application outlines methods for providing therapeutic benefits to patients with metabolic and pancreatic diseases. The method involves selecting a patient, identifying pancreatic deposit sites, and delivering a treatment agent through a depositing device. The application emphasizes the importance of advancing a depositing device to the selected sites for effective treatment.

Conclusion

Michael Biasella is making strides in the medical field, particularly in the treatment of metabolic diseases. His innovative approaches and ongoing research at Fractyl Health, Inc. hold promise for future advancements in patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…